-+ 0.00%
-+ 0.00%
-+ 0.00%

OS THERAPIES: EXPECTS TO COMPLETE EARLY MARKET ACCESS REGULATORY APPROVAL SUBMISSIONS FOR HERLYSTIC IN U.S., U.K., EUROPE AND AUSTRALIA IN Q4 2026

Reuters·10/19/2026 12:51:00

Please log in to view news